Deutsche Bank’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$883K Sell
8,824
-755
-8% -$75.3K ﹤0.01% 2304
2026
Q2
$908K Buy
9,579
+2,128
+29% +$213K ﹤0.01% 2428
2026
Q1
$501K Buy
7,451
+813
+12% +$60.3K ﹤0.01% 2577
2025
Q4
$524K Buy
+6,638
New +$452K ﹤0.01% 2538
2025
Q3
– Sell
-4,684
Closed -$66.8K – 3662
2025
Q2
$66.8K Sell
4,684
-2,759
-37% -$35.7K ﹤0.01% 3372
2025
Q1
$104K Sell
7,443
-12,166
-62% -$165K ﹤0.01% 3178
2024
Q4
$302K Buy
19,609
+19,487
+15,973% +$297K ﹤0.01% 2906
2024
Q3
$1.91K Hold
122
– – ﹤0.01% 3574
2024
Q2
$1.73K Buy
+122
New +$1.91K ﹤0.01% 3527

Other funds holding INBX

Deutsche Bank's INBX Position: Q3 2026 in Review

Deutsche Bank reduced its Inhibrx (INBX) stake by 7.9% in Q3 2026, selling an estimated $75.3K and leaving 8,824 shares worth $883K. The position accounts for ﹤0.01% of the portfolio, ranked #2304.

Deutsche Bank first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. The position peaked at $908K in Q2 2026. 173 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • Deutsche Bank held 8,824 shares of Inhibrx worth $883K as of Q3 2026.
  • Deutsche Bank sold 755 Inhibrx shares in Q3 2026, an estimated $75.3K.
  • Inhibrx made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2304 holding.
  • Deutsche Bank first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • Deutsche Bank's Inhibrx position peaked at $908K in Q2 2026.
  • 173 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.